flucytosine has been researched along with Acquired Immune Deficiency Syndrome in 55 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 9.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 9.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 7.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| "In patients with AIDS, silent persistent infection is common after clinically successful treatment for cryptococcal meningitis." | 6.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 5.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 5.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "Three patients with AIDS in whom multifocal choroiditis and choroidal lesions were the initial signs of disseminated cryptococcosis were treated with systemic amphotericin B and flucytosine." | 3.69 | Presumed multifocal cryptococcol choroidopathy prior to specific systemic manifestation. ( Dugel, PU; Kolahdouz-Isfahani, A; Rao, NA; Rostomian, K; Smith, RE; Thach, AB, 1997) |
| " She was treated with amphotericin B and flucytosine with some improvement, but on the 9th day she awoke with headache, drowsiness, and total blindness, although no papilledema." | 3.68 | Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. ( Ash, S; Cohen, J; Corbett, EL; Foster, O; Johnston, SR, 1992) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 3.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| " We examined four issues: the efficacy of treatment with amphotericin plus flucytosine as compared with amphotericin alone, the efficacy of suppressive therapy, the prognostic clinical characteristics, and the course of nonmeningeal cryptococcosis." | 3.67 | Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. ( Chuck, SL; Sande, MA, 1989) |
| "Cryptococcus neoformans strains from 26 individual patients with acquired immunodeficiency syndrome (AIDS) and three isolates from patients without AIDS were tested for their susceptibility to amphotericin B, flucytosine, ketoconazole, and miconazole nitrate." | 3.67 | In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome. ( Bottone, EJ; Cronin, DC; Poon, M; Wormser, GP, 1988) |
| " With the exception of a higher incidence of gastrointestinal side effects in the 2000mg cohort, both induction doses of FCZ were safe and well tolerated." | 3.30 | Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS ( Aberg, JA; Badal-Faesen, S; Bukuru, A; Clifford, DB; Hogg, E; Komarow, L; Lagat, D; Lalloo, UG; Langat, D; Larsen, RA; Mave, V; McKhann, A; Pillay, S; Samaneka, W; Supparatpinyo, K; Ticona, E, 2023) |
| "In patients with AIDS, silent persistent infection is common after clinically successful treatment for cryptococcal meningitis." | 2.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "Cryptococcosis is currently the most common life threatening mycoses found in patients with the acquired immunodeficiency syndrome (AIDS)." | 2.38 | Overview: cryptococcosis in the patient with AIDS. ( Sugar, AM, 1991) |
| "Cryptococcosis is the most common life-threatening mycosis with AIDS." | 2.38 | [Cryptococcosis in AIDS: therapeutic concepts]. ( Ruf, B, 1990) |
| "Treatment of cryptococcal meningitis in patients with AIDS with amphotericin B plus flucytosine is associated with a failure rate of 20%-30%." | 2.38 | Therapy for cryptococcal meningitis in patients with AIDS. ( Powderly, WG, 1992) |
| "Systemic fungal infections are life-threatening diseases that are occurring with increasing frequency, especially in immunocompromised patients." | 2.37 | Recent advances in the treatment of systemic fungal infections. ( Walsh, TJ, 1987) |
| "He had multiple prior episodes of cryptococcal meningitis with complications necessitating ventriculoperitoneal shunt placement and was on suppressive fluconazole when he developed worsening brain manifestations." | 1.56 | Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient. ( Jeng, A; Kalinoski, T; Malenfant, J; Yim, C, 2020) |
| "Despite evidence of unresolved cryptococcal meningitis, each patient underwent implantation of a VP shunt without complication and was discharged on lifetime fluconazole therapy." | 1.33 | The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis. ( McGirt, MJ; Rigamonti, D; Williams, MA; Woodworth, GF, 2005) |
| "The incidence of cryptococcal meningitis was increasing in the recent 5 years." | 1.31 | [A clinical study of 26 cases of cryptococcal meningitis]. ( Li, T; Liu, Z; Qin, S; Sheng, R; Wang, A, 2002) |
| "The isolates were from AIDS patients who had either died or had failed to show a clinical response during amphotericin B (AMB) treatment." | 1.31 | In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy. ( Cahn, P; Canteros, C; Córdoba, S; Davel, G; Guelfand, L; Hochenfellner, F; Kaufman, S; Rodero, L, 2000) |
| "neoformans from 120 Ugandan AIDS patients with cryptococcal meningitis by analyzing their electrophoretic karyotypes and antifungal susceptibility profiles." | 1.30 | Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. ( Ghannoum, M; Jessup, C; Mbidde, E; Messer, S; Pfaller, M; Tumberland, M; Zhang, J, 1998) |
| "Eighteen consecutive AIDS patients with a first episode of cryptococcal meningitis were enrolled in the study to evaluate the efficacy and tolerability of amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS." | 1.29 | Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. ( Jaruratanasirikul, S, 1996) |
| "albicans isolated from 24 patients with AIDS was compared with Candida isolated from 23 healthy adults." | 1.28 | Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. ( Kirsch, DR; Kwon-Chung, KJ; Smith, PD; Wahl, SM; Whelan, WL, 1990) |
| " Because amphotericin B nephrotoxicity was suspected, further intravenous administration was stopped after a cumulative dosage of 2 g." | 1.28 | [Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole]. ( Glück, T; Weber, P; Wiedmann, KH, 1991) |
| "Fluconazole has shown effectiveness in maintenance therapy, being not be possible to evaluate it as an acute phase therapy because the low number of cases in which it was studied." | 1.28 | [Cryptococcosis in AIDS patients: a study of 19 cases]. ( Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J, 1992) |
| "Patients with AIDS were younger and predominantly male; they had a shorter duration of prior illness, higher initial serum cryptococcal antigen titers, and lower initial cerebrospinal fluid white blood cell counts than those with neoplastic disease." | 1.28 | Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. ( Armstrong, D; Blevins, A; Cirrincione, C; White, M, 1992) |
| "All patients have an AIDS." | 1.28 | [Cryptococcosis in Bujumbura, Burundi. Apropos of 80 observed cases in 42 months]. ( Deppner, M; Dupont, B; Floch, JJ; Goasguen, J; Kadende, P; Laroche, R; Saunière, JF, 1990) |
| "Fungal infections have become one of the major causes of death among immunocompromised patients, particularly patients with AIDS." | 1.28 | Treating systemic fungal infections in AIDS patients. Prolonging life against the odds. ( Scheld, WM, 1990) |
| "Two patients with acquired immune deficiency syndrome presented with headaches and fevers." | 1.28 | Cryptococcal choroiditis. ( Carney, MD; Combs, JL; Waschler, W, 1990) |
| "Cryptococcosis is more frequently observed since the appearance of the acquired immunodeficiency syndrome (AIDS)." | 1.28 | [Cryptococcosis: presentation of 26 cases]. ( Azón, A; Gatell, JM; González-Clemente, JM; Mallolas, J; Mensa, J; Miró, JM; Moreno, A; Pedrol, E; Soriano, E, 1992) |
| "Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases." | 1.28 | Cryptococcosis in AIDS patients: observations concerning CNS involvement. ( de Matos-Marques, B; Pohle, HD; Rögler, G; Seibold, M; Sixt, C; Staib, F; Weinke, T, 1989) |
| "In two AIDS patients (homosexual men) microscopical demonstration of Cryptococcus neoformans in samples obtained by puncture of the liver (n = 1) and additionally of the spleen (n = 1) led to the diagnosis of systemic cryptococcosis." | 1.27 | [Disseminated cryptococcosis in 2 AIDS patients. A contribution to cryptococcosis diagnosis in AIDS]. ( Eichenlaub, D; Pohle, HD; Prüfer-Krämer, L; Rögler, G; Seibold, M; Staib, F, 1986) |
| "Cryptococcosis was the initial manifestation of the syndrome in 7 patients, and the initial opportunistic infection in an additional 7." | 1.27 | Cryptococcosis in the acquired immunodeficiency syndrome. ( Gelmann, EP; Gill, VJ; Kovacs, AA; Kovacs, JA; Lane, HC; Longfield, R; Overturf, G; Polis, M; Tuazon, CU; Wright, WC, 1985) |
| "The risk for AIDS patients from Cryptococcus neoformans is outlined on the basis of a case report on a 28-year old male patient whose disease was complicated by cryptococcosis." | 1.27 | [Cryptococcus neoformans meningoencephalitis in AIDS]. ( Bohle, C; Sinn, M; Staib, F; Werner, E, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (29.09) | 18.7374 |
| 1990's | 28 (50.91) | 18.2507 |
| 2000's | 5 (9.09) | 29.6817 |
| 2010's | 3 (5.45) | 24.3611 |
| 2020's | 3 (5.45) | 2.80 |
| Authors | Studies |
|---|---|
| Lalloo, UG | 1 |
| Komarow, L | 1 |
| Aberg, JA | 1 |
| Clifford, DB | 1 |
| Hogg, E | 1 |
| McKhann, A | 1 |
| Bukuru, A | 1 |
| Lagat, D | 1 |
| Pillay, S | 1 |
| Mave, V | 1 |
| Supparatpinyo, K | 2 |
| Samaneka, W | 1 |
| Langat, D | 1 |
| Ticona, E | 1 |
| Badal-Faesen, S | 1 |
| Larsen, RA | 3 |
| Kalinoski, T | 1 |
| Malenfant, J | 1 |
| Yim, C | 1 |
| Jeng, A | 1 |
| O'Connor, L | 1 |
| Van Anh, D | 1 |
| Chau, TTH | 1 |
| Chau, NVV | 1 |
| Huong, LNP | 1 |
| Wolbers, M | 1 |
| Day, JN | 1 |
| Chastain, DB | 1 |
| Guarner, J | 1 |
| Franco-Paredes, C | 1 |
| Jackson, AT | 1 |
| Nussbaum, JC | 1 |
| Phulusa, J | 1 |
| Namarika, D | 1 |
| Chikasema, M | 1 |
| Kanyemba, C | 1 |
| Jarvis, JN | 1 |
| Jaffar, S | 1 |
| Hosseinipour, MC | 1 |
| van der Horst, C | 1 |
| Harrison, TS | 1 |
| Munson, E | 1 |
| Olson, R | 1 |
| Liu, Z | 1 |
| Wang, A | 1 |
| Li, T | 1 |
| Qin, S | 1 |
| Sheng, R | 1 |
| Woodworth, GF | 1 |
| McGirt, MJ | 1 |
| Williams, MA | 1 |
| Rigamonti, D | 1 |
| Linthicum, FH | 1 |
| Krutikova, YV | 1 |
| Barbaro, G | 1 |
| Barbarini, G | 1 |
| Di Lorenzo, G | 1 |
| Hay, RJ | 1 |
| Nelson, KE | 1 |
| Merz, WG | 1 |
| Breslin, BJ | 1 |
| Cooper, CR | 1 |
| Kamwan, C | 1 |
| Sirisanthana, T | 1 |
| Finazzi, R | 1 |
| Guffanti, M | 1 |
| Cernuschi, M | 1 |
| Erembourg, L | 1 |
| Capasso, G | 1 |
| Ossi, C | 1 |
| Gesu, G | 1 |
| Jaruratanasirikul, S | 1 |
| Rostomian, K | 1 |
| Dugel, PU | 1 |
| Kolahdouz-Isfahani, A | 1 |
| Thach, AB | 1 |
| Smith, RE | 1 |
| Rao, NA | 1 |
| Pfaller, M | 1 |
| Zhang, J | 1 |
| Messer, S | 1 |
| Tumberland, M | 1 |
| Mbidde, E | 1 |
| Jessup, C | 1 |
| Ghannoum, M | 1 |
| Casper, T | 1 |
| Basset, D | 1 |
| Leclercq, C | 1 |
| Fabre, J | 1 |
| Peyron-Raison, N | 1 |
| Reynes, J | 1 |
| Rodero, L | 1 |
| Córdoba, S | 1 |
| Cahn, P | 1 |
| Hochenfellner, F | 1 |
| Davel, G | 1 |
| Canteros, C | 1 |
| Kaufman, S | 1 |
| Guelfand, L | 1 |
| Rambeloarisoa, J | 1 |
| Batisse, D | 1 |
| Thiebaut, JB | 1 |
| Mikol, J | 1 |
| Mrejen, S | 1 |
| Karmochkine, M | 1 |
| Kazatchkine, MD | 1 |
| Weiss, L | 1 |
| Piketty, C | 1 |
| de Gans, J | 1 |
| Portegies, P | 1 |
| Tiessens, G | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| van Boxtel, CJ | 1 |
| van Ketel, RJ | 1 |
| Stam, J | 1 |
| Eloy, O | 1 |
| Joly, V | 1 |
| Ghnassia, JC | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| Powderly, WG | 1 |
| Pedrol, E | 1 |
| Mallolas, J | 1 |
| González-Clemente, JM | 1 |
| Miró, JM | 1 |
| Azón, A | 1 |
| Gatell, JM | 1 |
| Moreno, A | 1 |
| Mensa, J | 1 |
| Soriano, E | 1 |
| Johnston, SR | 1 |
| Corbett, EL | 1 |
| Foster, O | 1 |
| Ash, S | 1 |
| Cohen, J | 1 |
| White, M | 1 |
| Cirrincione, C | 1 |
| Blevins, A | 1 |
| Armstrong, D | 1 |
| Gazapo Carretero, E | 1 |
| García Aguado, C | 1 |
| Adrados de Llano, M | 1 |
| Martínez Blanco, ML | 1 |
| Verdejo Ortes, J | 1 |
| González Lahoz, JM | 1 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Salavert, M | 1 |
| Carrasco, R | 1 |
| Roig, P | 1 |
| Nieto, A | 1 |
| Cervelló, A | 1 |
| Navarro, V | 1 |
| Buxton, MJ | 1 |
| Dubois, DJ | 1 |
| Turner, RR | 1 |
| Sculpher, MJ | 1 |
| Robinson, PA | 1 |
| Searcy, C | 1 |
| Sugar, AM | 1 |
| Whelan, WL | 1 |
| Kirsch, DR | 1 |
| Kwon-Chung, KJ | 1 |
| Wahl, SM | 1 |
| Smith, PD | 1 |
| Bozzette, SA | 1 |
| Chiu, J | 1 |
| Leal, MA | 2 |
| Jacobsen, J | 1 |
| Rothman, P | 1 |
| Robinson, P | 1 |
| Gilbert, G | 1 |
| McCutchan, JA | 1 |
| Tilles, J | 1 |
| Ruf, B | 1 |
| Chan, LS | 1 |
| Laroche, R | 1 |
| Deppner, M | 1 |
| Floch, JJ | 1 |
| Kadende, P | 1 |
| Goasguen, J | 1 |
| Saunière, JF | 1 |
| Dupont, B | 1 |
| Wong, RD | 1 |
| Goetz, MB | 1 |
| Scheld, WM | 1 |
| Carney, MD | 1 |
| Combs, JL | 1 |
| Waschler, W | 1 |
| Picon, L | 1 |
| Vaillant, L | 1 |
| Duong, T | 1 |
| Lorette, G | 1 |
| Bacq, Y | 1 |
| Besnier, JM | 1 |
| Choutet, P | 1 |
| Hernandez, AD | 1 |
| Chuck, SL | 1 |
| Sande, MA | 1 |
| Walsh, TJ | 1 |
| Weinke, T | 1 |
| Rögler, G | 2 |
| Sixt, C | 1 |
| de Matos-Marques, B | 1 |
| Pohle, HD | 2 |
| Staib, F | 4 |
| Seibold, M | 3 |
| Kotani, S | 1 |
| Hirose, S | 1 |
| Niiya, K | 1 |
| Kubonishi, I | 1 |
| Miyoshi, I | 1 |
| Orefice, G | 1 |
| Carrieri, PB | 1 |
| Vecchione, V | 1 |
| Chirianni, A | 1 |
| Tullio-Cataldo, P | 1 |
| Striano, S | 1 |
| Poon, M | 1 |
| Cronin, DC | 1 |
| Wormser, GP | 1 |
| Bottone, EJ | 1 |
| Eng, RH | 1 |
| Bishburg, E | 1 |
| Smith, SM | 1 |
| Kapila, R | 1 |
| Guérin, JM | 1 |
| Lebiez, PE | 1 |
| Segrestaa, JM | 1 |
| Prüfer-Krämer, L | 1 |
| Eichenlaub, D | 1 |
| Kovacs, JA | 1 |
| Kovacs, AA | 1 |
| Polis, M | 1 |
| Wright, WC | 1 |
| Gill, VJ | 1 |
| Tuazon, CU | 1 |
| Gelmann, EP | 1 |
| Lane, HC | 1 |
| Longfield, R | 1 |
| Overturf, G | 1 |
| Zuger, A | 1 |
| Louie, E | 1 |
| Holzman, RS | 1 |
| Simberkoff, MS | 1 |
| Rahal, JJ | 1 |
| Bohle, C | 1 |
| Sinn, M | 1 |
| Werner, E | 1 |
| McCluskey, PJ | 1 |
| Wakefield, D | 1 |
6 reviews available for flucytosine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th | 1992 |
Therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Animals; Fluconazole; Flucytosine; Humans; Menin | 1992 |
Overview: cryptococcosis in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans | 1991 |
[Cryptococcosis in AIDS: therapeutic concepts].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Fluco | 1990 |
Cutaneous cryptococcosis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Biopsy; Cryptococcosis; Cryptococcus neoformans; | 1989 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; D | 1987 |
7 trials available for flucytosine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 2023 |
Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Fluconazole; Flucytosine; Humans; Meningitis, | 2021 |
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Opportunistic In | 2012 |
Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 1992 |
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Cryptococcosis; Double-Blind Method; Drug Evaluatio | 1991 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1990 |
42 other studies available for flucytosine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents | 2020 |
Cryptococcal antigen negative meningoencephalitis in HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryp | 2017 |
Photo quiz: a 38-year-old male with a 3-month history of abdominal pain, constipation, and headache.
Topics: Abdominal Pain; Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; CD4 Ly | 2012 |
[A clinical study of 26 cases of cryptococcal meningitis].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Child; Cryptococcus; Drainage | 2002 |
The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dr | 2005 |
Temporal bone histopathology case of the month: acute hearing loss due to cryptococcal meningitis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Anti-Bacterial Agents; Cochlear Nerve; Cr | 2007 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Cryptococcosis, AIDS, and clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Resistance; Drug Therapy, C | 1995 |
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Flucytosine; Humans; | 1993 |
Unusual presentation of cryptococcosis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 1996 |
Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 1996 |
Presumed multifocal cryptococcol choroidopathy prior to specific systemic manifestation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Choroiditis; Cryptococ | 1997 |
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cluster Analysis; Cryptococcus neoformans; DN | 1998 |
Disseminated acanthamoeba infection in a patient with AIDS: response to 5-fluorocytosine therapy.
Topics: Acanthamoeba; Acquired Immunodeficiency Syndrome; Adult; Amebiasis; Animals; Female; Flucytosine; Hu | 1999 |
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus | 2000 |
Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 2002 |
[Cryptococcosis: presentation of 26 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Amphotericin B; Antigens, Fungal | 1992 |
Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Blindness; Cranial Nerve Diseases; Crypto | 1992 |
Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1992 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug T | 1991 |
[Meningitis caused by Candida albicans in a male patient infected by HIV and failure of treatment with amphotericin B].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; F | 1991 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Costs and Cost Analysis; C | 1991 |
Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain.
Topics: Acquired Immunodeficiency Syndrome; Bacterial Typing Techniques; Candida albicans; Candidiasis; Carb | 1990 |
[Cryptococcosis in Bujumbura, Burundi. Apropos of 80 observed cases in 42 months].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Burundi; Cryptococcosis; Drug Thera | 1990 |
Treatment of cryptococcal meningitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Flucytosine; Humans; Meningitis | 1990 |
Treating systemic fungal infections in AIDS patients. Prolonging life against the odds.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Azoles; Candidiasis; Cryptoco | 1990 |
Cryptococcal choroiditis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Fungal; Choroiditis; Cryptococc | 1990 |
Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Cryptococcosis; Diagnosis, Differential; Flucytos | 1989 |
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neofor | 1989 |
Cryptococcosis in AIDS patients: observations concerning CNS involvement.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male | 1989 |
Anaphylaxis to flucytosine in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anaphylaxis; Drug Hypersensitivity; Flucytosine; Humans; | 1988 |
Cryptococcal meningitis in AIDS patients. A two-case report.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, | 1988 |
In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus ne | 1988 |
Mycological-diagnostic assessment of the efficacy of amphotericin B + flucytosine to control Cryptococcus neoformans in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Dose-Response Relationshi | 1988 |
Cryptococcal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antigens, Fungal; Cryptococcosis; Cryptococcus n | 1986 |
[Acute disseminated cryptococcosis disclosing AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Amphotericin B; Cryptococcosis; Flucytosin | 1987 |
[Disseminated cryptococcosis in 2 AIDS patients. A contribution to cryptococcosis diagnosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male | 1986 |
Cryptococcosis in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Cryptococc | 1985 |
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Brain Diseases; Cryptococcosis; Drug Ther | 1986 |
[Cryptococcus neoformans meningoencephalitis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, Combination | 1986 |
Ocular involvement in the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis, Oral; Cryptococcosis; Eyelid | 1985 |